These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 749987)

  • 21. Does increased platelet aggregation have a prognostic value in the deterioration of background diabetic retinopathy? The Damad Study Group.
    Plu G; Lecrubier C; Scarabin PY; Baudoin C; Samama M
    Thromb Haemost; 1990 Oct; 64(2):202-5. PubMed ID: 2270529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Letter: platelet aggregation and assay of Willebrand factor during diabetes mellitus].
    Bensoussan D; Passa P; Canivet J; Lévy-Toledano S; Caen J
    Nouv Presse Med; 1975 Jan; 4(3):195. PubMed ID: 1129082
    [No Abstract]   [Full Text] [Related]  

  • 23. [Changes in general hemostasis in patients with diabetic retinopathy].
    Evgrafov VIu; Markova OA; Grishin VL; Efimov VS
    Vestn Oftalmol; 2004; 120(3):29-31. PubMed ID: 15216770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of activated autoplasma on platelet aggregation in patients with vascular diseases of the fundus oculi].
    Mukha AI; Lysenko VS; Galileeva VV; Bunin AIa
    Vestn Oftalmol; 1998; 114(3):32-4. PubMed ID: 9720397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Adequacy of prescribing the disaggregants in vascular pathology of the eye fundus and in primary open-angle glaucoma].
    Mukha AI
    Vestn Oftalmol; 2005; 121(1):30-3. PubMed ID: 15759845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Significance of serotonin in the pathogenesis of diabetic retinopathy and central chorioretinal dystrophy].
    Mukha AI; Korzenkova LV; Fedorova NV; Syromiatnikova ED
    Vestn Oftalmol; 2002; 118(4):31-3. PubMed ID: 12371320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fibrinolytic response in retinal venous occlusions and in diabetic retinopathy].
    Peduzzi M; De Rosa L; Montanari F; Coccheri S
    Bull Mem Soc Fr Ophtalmol; 1978; 90():79-82. PubMed ID: 750023
    [No Abstract]   [Full Text] [Related]  

  • 28. Plasma fibrinopeptide A, beta-thromboglobulin, and platelet factor 4 in diabetic retinopathy.
    Roy MS; Podgor MJ; Rick ME
    Invest Ophthalmol Vis Sci; 1988 Jun; 29(6):856-60. PubMed ID: 2967258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A modification of the Wu and Hoak method for the determination of platelet aggregates and platelet adhesion.
    Bowry SK; Prentice CR; Courtney JM
    Thromb Haemost; 1985 Jun; 53(3):381-5. PubMed ID: 3931286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of aspirin on prostanoids and nitric oxide production in streptozotocin-diabetic rats with ischemic retinopathy.
    De La Cruz P; Guerrero A; Paniego J; Arranz I; Moreno A; Sánchez De La Cuesta F
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):96-101. PubMed ID: 11819026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of beraprost sodium, a stable prostaglandin I2 analogue, on platelet aggregation in diabetes mellitus.
    Kato H; Takashima T; Kishikawa H; Emura S; Ohmori K
    Int J Clin Pharmacol Res; 1996; 16(4-5):99-102. PubMed ID: 9172007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet P-selectin plays an important role in arterial thrombogenesis by forming large stable platelet-leukocyte aggregates.
    Yokoyama S; Ikeda H; Haramaki N; Yasukawa H; Murohara T; Imaizumi T
    J Am Coll Cardiol; 2005 Apr; 45(8):1280-6. PubMed ID: 15837262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet coagulant activities in diabetes mellitus. Evidence for relationship between platelet coagulant hyperactivity and platelet volume.
    Rao AK; Goldberg RE; Walsh PN
    J Lab Clin Med; 1984 Jan; 103(1):82-92. PubMed ID: 6690642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Detection of platelet aggregates using light scattering].
    Satoh K; Ozaki Y; Kume S
    Rinsho Byori; 1995 May; 43(5):426-31. PubMed ID: 7783359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Erythrocyte aggregation in vivo and diabetic microangiopathy. Physiopathologic determinants and clinical correlations].
    Benhamou PY; Carpentier P; Halimi S; Bertrand C; Mouillon M; Franco A
    Diabete Metab; 1990; 16(3):192-8. PubMed ID: 2210013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The filtragometer: a new device for measuring platelet aggregation in venous blood of man.
    Hornstra G; ten Hoor F
    Thromb Diath Haemorrh; 1975 Nov; 34(2):531-44. PubMed ID: 1198411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Biophysical mechanisms and kinetics of thrombocyte aggregation].
    Gavrilov VB; Khovratovich VI
    Tsitologiia; 1984 Dec; 26(12):1401-8. PubMed ID: 6528363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular abnormalities in diabetes and their treatment.
    Kohner EM; Porta M
    Trans Ophthalmol Soc U K (1962); 1980 Sep; 100(3):440-4. PubMed ID: 6795769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effect of cephalexin on thrombocyte function in diabetics and normal persons].
    Peters KM; Reuter HD
    Arzneimittelforschung; 1987 Jul; 37(7):843-6. PubMed ID: 3675681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pathogenetic mechanisms of platelet hyperaggregation in diabetics (author's transl)].
    Amado Señars JA; García-Conde Bru J; Merino Sánchez J; Benet Monforte I
    Sangre (Barc); 1981; 26(4):409-16. PubMed ID: 7027491
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.